相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Worldwide, 3-Year, Post-Marketing Surveillance Experience with Tofacitinib in Rheumatoid Arthritis
Stanley Cohen et al.
RHEUMATOLOGY AND THERAPY (2018)
An association of periostin levels with the severity and chronicity of atopic dermatitis in children
Myongsoon Sung et al.
PEDIATRIC ALLERGY AND IMMUNOLOGY (2017)
Topical tofacitinib for atopic dermatitis: a phase IIa randomized trial
R. Bissonnette et al.
BRITISH JOURNAL OF DERMATOLOGY (2016)
Interleukin 22 early affects keratinocyte differentiation, but not proliferation, in a three-dimensional model of normal human skin
Elena Donetti et al.
EXPERIMENTAL CELL RESEARCH (2016)
Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: Long-term efficacy and safety results from 2 randomized phase-III studies and 1 open-label long-term extension study
Kim A. Papp et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2016)
The JAK-STAT Pathway: Impact on Human Disease and Therapeutic Intervention
John J. O'Shea et al.
ANNUAL REVIEW OF MEDICINE, VOL 66 (2015)
Tumor necrosis factor-alpha and interleukin-17 differently affects Langerhans cell distribution and activation in an innovative three-dimensional model of normal human skin
Francesca Prignano et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2015)
The Janus kinase inhibitor JTE-052 improves skin barrier function through suppressing signal transducer and activator of transcription 3 signaling
Wataru Amano et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Characterization of a Novel Standardized Human Three-Dimensional Skin Wound Healing Model Using Non-Sequential Fractional Ultrapulsed CO2 Laser Treatments
Yvonne Marquardt et al.
LASERS IN SURGERY AND MEDICINE (2015)
Pharmacological properties of JTE-052: a novel potent JAK inhibitor that suppresses various inflammatory responses in vitro and in vivo
Atsuo Tanimoto et al.
INFLAMMATION RESEARCH (2015)
Periostin levels correlate with disease severity and chronicity in patients with atopic dermatitis
K. Kou et al.
BRITISH JOURNAL OF DERMATOLOGY (2014)
Reversal of CD8 T-Cell-Mediated Mucocutaneous Graft-Versus-Host-Like Disease by the JAK Inhibitor Tofacitinib
Naoko Okiyama et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
Periostin in Skin Tissue and Skin-Related Diseases
Yukie Yamaguchi
ALLERGOLOGY INTERNATIONAL (2014)
New therapies under development for psoriasis treatment
Martha-Estrella Garcia-Perez et al.
CURRENT OPINION IN PEDIATRICS (2013)
IL-31 regulates differentiation and filaggrin expression in human organotypic skin models
Christian Cornelissen et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
Periostin promotes chronic allergic inflammation in response to Th2 cytokines
Miho Masuoka et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Dexpanthenol Modulates Gene Expression in Skin Wound Healing in vivo
R. Heise et al.
SKIN PHARMACOLOGY AND PHYSIOLOGY (2012)
Periostin Contributes to the Pathogenesis of Atopic Dermatitis by Inducing TSLP Production from Keratinocytes
Hiroshi Shiraishi et al.
ALLERGOLOGY INTERNATIONAL (2012)
Stat6 and c-Jun Mediate Th2 Cell-Specific IL-24 Gene Expression
Anupama Sahoo et al.
JOURNAL OF IMMUNOLOGY (2011)
Integrative Responses to IL-17 and TNF-α in Human Keratinocytes Account for Key Inflammatory Pathogenic Circuits in Psoriasis
Andrea Chiricozzi et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2011)
Mutual Antagonism of T Cells Causing Psoriasis and Atopic Eczema
Stefanie Eyerich et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
IL-24 Transgenic Mice: In Vivo Evidence of Overlapping Functions for IL-20, IL-22, and IL-24 in the Epidermis
Miao He et al.
JOURNAL OF IMMUNOLOGY (2010)
Expression and Induction of Cytochrome P450 Isoenzymes in Human Skin Equivalents
M. M. Neis et al.
SKIN PHARMACOLOGY AND PHYSIOLOGY (2010)
Interleukin-20 plays a critical role in maintenance and development of psoriasis in the human xenograft transplantation model
K. Stenderup et al.
BRITISH JOURNAL OF DERMATOLOGY (2009)
IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-γ are not
Kerstin Wolk et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2009)
Mechanisms of Disease: Psoriasis.
Frank O. Nestle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Targeting signaling pathways with small molecules to treat autoimmune disorders
Bozena Kaminska et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2008)
Cytokine signaling modules in inflammatory responses
John J. O'Shea et al.
IMMUNITY (2008)
Mechanisms of disease: Atopic dermatitis
Thomas Bieber
NEW ENGLAND JOURNAL OF MEDICINE (2008)
IL-20 gene expression is induced by IL-1β through mitogen-activated protein kinase and NF-κB-dependent mechanisms
Kristian Otkjaer et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2007)
Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides
Spencer C. Liang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes:: a potential role in psoriasis
Kerstin Wolk et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2006)
Regulation of the transcription factor FOXM1c by Cyclin E/CDK2
JM Lüscher-Firzlaff et al.
FEBS LETTERS (2006)
The dynamics of gene expression of interleukin-19 and interleukin-20 and their receptors in psoriasis
K Otkjaer et al.
BRITISH JOURNAL OF DERMATOLOGY (2005)
分享论文
